Llorca P

Department of Psychiatry, CHU Clermont-Ferrand, University of Clermont Auvergne , CNRS, Auvergne INP, Institute Pascal (UMR 6602), Clermont-Ferrand

3 papers

ArticleKetamine

Patient reported outcomes of MDD patients treated with esketamine nasal spray in real world practice: the French ELLIPSE study

Llorca P, Samalin L, Olié E +4

Europe PMC2026
ArticleKetamine

Improvements in Functioning with Esketamine Nasal Spray versus Quetiapine Extended Release in Patients with Treatment Resistant Depression

Vieta E, Ahmed N, Arango C +11

Europe PMC2025
ArticleKetamine

Real world clinical practice, efficacy and safety of esketamine nasal spray in MDD patients: the French ELLIPSE study

Llorca P, Mékaoui L, Rotharmel M +4

Europe PMC2025